Diabetes, insulin resistance,and metabolic syndrome in horses

Journal of Diabetes Science and Technology

Volumn 6, Issue 3, 2012, Pages 534-540

  Johnson, Philip J ^a   Wiedmeyer, Charles E ^a   LaCarrubba, Alison ^a   Ganjam, V K ^a   Messer IV, Nat T ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Diabetes; Glucose; Horse; Insulin; Laminitis; Metabolic syndrome

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL CARE; CONFERENCE PAPER; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE PREDISPOSITION; GLUCOSE BLOOD LEVEL; HOOF AND CLAW; HORSE DISEASE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; METABOLIC SYNDROME X; NONHUMAN; PHARMACEUTICAL CARE; PHYSICAL INACTIVITY; VETERINARY CLINIC; ANIMAL; ANIMAL DISEASE; BLOOD; DISEASE COURSE; HORSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RISK FACTOR;

ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; HORSE DISEASES; HORSES; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PROGNOSIS; RISK FACTORS;

EID: 84875893479     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600307     Document Type: Conference Paper

References (71)

1. Johnson PJ. The equine metabolic syndrome peripheral Cushing's syndrome. Vet Clin North Am Equine Pract. 2002;18(2):271-93.
2. Frank N, Geor RJ, Bailey SR, Durham AE, Johnson PJ; American College of Veterinary Internal Medicine. Equine metabolic syndrome. J Vet Intern Med. 2010;24(3):467-75.
3. Frank N. Equine metabolic syndrome. Vet Clin North Am Equine Pract. 2011;27(1):73-92.
4. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-80.
5. Day C. Metabolic syndrome, or what you will: definitions and epidemiology. Diab Vasc Dis Res. 2007;4(1):32-8. (Pubitemid 46649071)
6. Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PW. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007;30(5):1219-25. (Pubitemid 46684651)
7. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schifrin EL, Eisenberg MJ. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113-32.
8. De Nunzio C, Aronson W, Freedland SJ, Giovannucci E, Parsons JK. The Correlation Between Metabolic Syndrome and Prostatic Diseases. Eur Urol. 2012;61(3):560-70.
9. Hammarsten J, Peeker R. Urological aspects of the metabolic syndrome. Nat Rev Urol. 2011;8(9):483-94.
10. Fraile JM, Puig JG, Torres RJ, de Miguel E, Martínez P, Vázquez JJ. Uric acid metabolism in patients with primary gout and the metabolic syndrome. Nucleosides Nucleotides Nucleic Acids. 2010;29(4-6):330-4.
11. Baranova A, Tran TP, Birerdinc A, Younossi ZM. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011;33(7):801-14.
12. Lurie A. Metabolic disorders associated with obstructive sleep apnea in adults. Adv Cardiol. 2011;46:67-138.
13. Gallagher EJ, Leroith D, Karnieli E. The metabolic syndrome - from insulin resistance to obesity and diabetes. Med Clin North Am. 2011;95(5):855-73.
14. García-Lara JM, Aguilar-Navarro S, Gutiérrez-Robledo LM, Avila-Funes JA. The metabolic syndrome, diabetes, and Alzheimer's disease. Rev Invest Clin. 2010;62(4):343-9.
15. McGinley B, Punjabi NM. Obesity, metabolic abnormalities, and asthma: establishing causal links. Am J Respir Crit Care Med. 2011;183(4):424-5.
16. Chang Y, Sung E, Ryu S, Park YW, Jang YM, Park M. Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men. J Korean Med Sci. 2008;23(4):644-50.
17. Scorletti E, Calder PC, Byrne CD. Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments. Endocrine. 2011;40(3):332-43.
18. Gottlieb AB, Dann F. Comorbidities in patients with psoriasis. Am J Med. 2009;122(12):1150.e1-9.
19. Vick MM, Adams AA, Murphy BA, Sessions DR, Horohov DW, Cook RF, Shelton BJ, Fitzgerald BP. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. J Anim Sci. 2007;85(5):1144-55. (Pubitemid 46693411)
20. Vick MM, Murphy BA, Sessions DR, Reedy SE, Kennedy EL, Horohov DW, Cook RF, Fitzgerald BP. Efects of systemic inflammation on insulin sensitivity in horses and inflammatory cytokine expression in adipose tissue. Am J Vet Res. 2008;69(1):130-9. (Pubitemid 351181581)
21. Bailey SR, Habershon-Butcher JL, Ransom KJ, Elliott J, Menzies-Gow NJ. Hypertension and insulin resistance in a mixed-breed population of ponies predisposed to laminitis. Am J Vet Res. 2008;69(1):122-9. (Pubitemid 351181580)
22. Rugh KS, Garner HE, Sprouse RF, Hatfield DG. Left ventricular hypertrophy in chronically hypertensive ponies. Lab Anim Sci. 1987;37(3):335-8.
23. Carter RA, Treiber KH, Geor RJ, Douglass L, Harris PA. Prediction of incipient pasture-associated laminitis from hyperinsulinaemia, hyperleptinaemia and generalised and localised obesity in a cohort of ponies. Equine Vet J. 2009;41(2):171-8.
24. Johnson PJ, Wiedmeyer CE, Messer NT, Ganjam VK. Medical implications of obesity in horses - lessons for human obesity. J Diabetes Sci Technol. 2009;3(1):163-74.
25. Waitt LH, Cebra CK. Characterization of hypertriglyceridemia and response to treatment with insulin in horses, ponies, and donkeys: 44 cases (1995-2005). J Am Vet Med Assoc. 2009;234(7):915-9.
26. Ralston SL. Hyperglycemia/hyperinsulinemia after feeding a meal of grain to young horses with osteochondritis dissecans (OCD) lesions. Pferdeheilkunde. 1996;12:320-2.
27. Durham AE, Hughes KJ, Cottle HJ, Rendle DI, Boston RC. Type 2 diabetes mellitus with pancreatic beta cell dysfunction in 3 horses confirmed with minimal model analysis. Equine Vet J. 2009;41(9):924-9.
28. Johnson PJ, Scotty NC, Wiedmeyer C, Messer NT, Kreeger JM. Diabetes mellitus in a domesticated Spanish mustang. J Am Vet Med Assoc. 2005;226(4):584-8. (Pubitemid 40239207)
29. Yki-Järvinen H. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig Dis. 2010;28(1):203-9.
30. Stogdale L. Definition of diabetes mellitus. Cornell Vet. 1986;76(2):156-74.
31. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55(1):65-85. (Pubitemid 34036538)
32. Messer NT 4th, Johnson PJ. Evidence-based literature pertaining to thyroid dysfunction and Cushing's syndrome in the horse. Vet Clin North Am Equine Pract. 2007;23(2):329-64. (Pubitemid 47007743)
33. McFarlane D, Dybdal N, Donaldson MT, Miller L, Cribb AE. Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction. J Neuroendocrinol. 2005;17(2):73-80. (Pubitemid 40425628)
34. McFarlane D. Advantages and limitations of the equine disease, pituitary pars intermedia dysfunction as a model of spontaneous dopaminergic neurodegenerative disease. Ageing Res Rev. 2007;6(1):54-63. (Pubitemid 46635285)
35. McGowan CM, Frost R, Pfeifer DU, Neiger R. Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value. Equine Vet J. 2004;36(3):295-8. (Pubitemid 38698823)
36. Jorgenson GE. Interesting case of pancreatic glycosurea. J Am Vet Med Assoc. 1921;58:718-9.
37. Jefrey JR. Diabetes mellitus secondary to chronic pancreatitis in a pony. J Am Vet Med Assoc. 1968;153(9):1168-75.
38. Bulgin MS, Anderson BC. Verminous arteritis and pancreatic necrosis with diabetes mellitus in a pony. Compend Contin Educ Pract Vet. 1983;5:S482-S285.
39. McCoy DJ. Diabetes mellitus associated with bilateral granulosa cell tumors in a mare. J Am Vet Med Assoc. 1986;188(7):733-5.
40. Giri JK, Magdesian KG, Gafney PM. Insulin-dependent diabetes mellitus associated with presumed autoimmune polyendocrine syndrome in a mare. Can Vet J. 2011;52(5):506-12.
41. Ruof WW, Baker DC, Morgan SJ, Abbitt B. Type II diabetes mellitus in a horse. Equine Vet J. 1986;18(2):143-4.
42. Tasker JB, Whiteman CE, Martin BR. Diabetes mellitus in the horse. J Am Vet Med Assoc. 1966;149(4):393-9.
43. Baker JR, Ritchie HE. Diabetes mellitus in the horse: a case report and review of the literature. Equine Vet J. 1974;6(1):7-11.
44. Muylle E, van den Hende C, Deprez P, Nuytten J, Oyaert W. Non-insulin dependent diabetes mellitus in a horse. Equine Vet J. 1986;18(2):145-6.
45. Navas de Solis C, Foreman JH. Transient diabetes mellitus in a neonatal Thoroughbred foal. J Vet Emerg Crit Care (San Antonio). 2010;20(6):611-5.
46. Aguilar-Bryan L, Bryan J. Neonatal diabetes mellitus. Endocrine Rev. 2008;29:265-91. (Pubitemid 351679699)
47. Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47(3):193-9.
48. Craighead JE. The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus. Prog Med Virol. 1975;19:161-214.
49. Ballotti S, de Martino M. Rotavirus infections and development of type 1 diabetes: an evasive conundrum. J Pediatr Gastroenterol Nutr. 2007;45(2):147-56. (Pubitemid 47220519)
50. Van der Werf N, Kroese FG, Rozing J, Hillebrands JL. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev. 2007;23(3):169-83. (Pubitemid 46437842)
51. Scroggie DA, Albright A, Harris MD. The efect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Arch Intern Med. 2003;163(13):1587-90. (Pubitemid 36835104)
52. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55(1):65-85. (Pubitemid 34036538)
53. Kumar PR, Bhansali A, Ravikiran M, Bhansali S, Dutta P, Thakur JS, Sachdeva N, Bhadada SK, Walia R. Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. J Clin Endocrinol Metab. 2010;95(6):2832-5.
54. Tinworth KD, Wynn PC, Boston RC, Harris PA, Sillence MN, Thevis M, Thomas A, Noble GK. Evaluation of commercially available assays for the measurement of equine insulin. Domest Anim Endocrinol. 2011;41(2):81-90.
55. Johnson PJ, Wiedmeyer CE, LaCarrubba A, Ganjam VK, Messer NT 4th. Laminitis and the equine metabolic syndrome. Vet Clin North Am Equine Pract. 2010;26(2):239-55.
56. Eiler H, Frank N, Andrews FM, Oliver JW, Fecteau KA. Physiologic assessment of blood glucose homeostasis via combined intravenous glucose and insulin testing in horses. Am J Vet Res. 2005;66(9):1598-604. (Pubitemid 41614672)
57. Schuver A. Use of an oral sugar test to assess insulin sensitivity in healthy and insulin resistant horses [abstract]. J Vet Intern Med. 2010;24(3):780.
58. Wiedmeyer CE, Johnson PJ, Cohn LA, Meadows RL. Evaluation of a continuous glucose monitoring system for use in dogs, cats, and horses. J Am Vet Med Assoc. 2003;223(7):987-92. (Pubitemid 37169728)
59. Wiedmeyer CE, Johnson PJ, Cohn LA, Meadows RL, Kerl ME, Tessman RK, Perlis J, DeClue AE. Evaluation of a continuous glucose monitoring system for use in veterinary medicine. Diabetes Technol Ther. 2005;7(6):885-95. (Pubitemid 43133995)
60. Johnson PJ, Wiedmeyer CE, LaCarrubba A, Messer NT, Dingfelder HA, Cogswell AM, Amorim JR, Ganjam VK. Clinical assessment of blood glucose homeostasis in horses: comparison of a continuous glucose monitoring system with a combined intravenous glucose and insulin test protocol. J Vet Intern Med. 2011;25(1):162-5.
61. Carter RA, Treiber KH, Geor RJ, Douglass L, Harris PA. Prediction of incipient pasture-associated laminitis from hyperinsulinaemia, hyperleptinaemia and generalised and localised obesity in a cohort of ponies. Equine Vet J. 2009;41(2):171-8.
62. Powell DM, Reedy SE, Sessions DR, Fitzgerald BP. Efect of short-term exercise training on insulin sensitivity in obese and lean mares. Equine Vet J Suppl. 2002;(34):81-4.
63. Lacombe VA, Hinchclif KW, Devor ST. Efects of exercise and glucose administration on content of insulin-sensitive glucose transporter in equine skeletal muscle. Am J Vet Res. 2003;64(12):1500-6. (Pubitemid 37527261)
64. Nout YS, Hinchclif KW, Jose-Cunilleras E, Dearth LR, Sivko GS, DeWille JW. Efect of moderate exercise immediately followed by induced hyperglycemia on gene expression and content of the glucose transporter-4 protein in skeletal muscles of horses. Am J Vet Res. 2003;64(11):1401-8. (Pubitemid 37407393)
65. Sandoval DA, Guy DL, Richardson MA, Ertl AC, Davis SN. Efects of low and moderate antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes. Diabetes. 2004;53(7):1798-806. (Pubitemid 38857038)
66. Giannarelli R, Aragona M, Coppelli A, Del Prato S. Reducing insulin resistance with metformin: the evidence today. Diabetes Metab. 2003;29(4 Pt 2):6S28-35.
67. Marchetti P, Del Guerra S, Marselli L, Lupi R, Masini M, Pollera M, Bugliani M, Boggi U, Vistoli F, Mosca F, Del Prato S. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab. 2004;89(11):5535-41. (Pubitemid 39518437)
68. Hustace JL, Firshman AM, Mata JE. Pharmacokinetics and bioavailability of metformin in horses. Am J Vet Res. 2009;70(5):665-8.
69. Wearn JM, Crisman MV, Davis JL, Geor RJ, Hodgson DR, Suagee JK, Ashraf-Khorassani M, McCutcheon LJ. Pharmacokinetics of pioglitazone after multiple oral dose administration in horses. J Vet Pharmacol Ther. 2011;34(3):252-8.
70. Wearn JG, Suagee JK, Crisman MV, Corl BA, Hulver MW, Hodgson DR, Geor RJ, McCutcheon LJ. Efects of the insulin sensitizing drug, pioglitazone, and lipopolysaccharide administration on markers of systemic inflammation and clinical parameters in horses. Vet Immunol Immunopathol. 2012;145(1-2):42-9.
71. Suagee JK, Corl BA, Wearn JG, Crisman MV, Hulver MW, Geor RJ, McCutcheon LJ. Efects of the insulin-sensitizing drug pioglitazone and lipopolysaccharide administration on insulin sensitivity in horses. J Vet Intern Med. 2011;25(2):356-64.